Anticorps Monoclonal anti-ASGR2

ASGR2 Monoclonal Antibody for WB, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, rat

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2A5C12

N° de cat : 66831-1-PBS

Synonymes

ASGP R, ASGP R 2, ASGPR 2, ASGR2, asialoglycoprotein receptor 2, CLEC4H2, Hepatic lectin H2, HL 2, Hs.1259, L H2



Informations sur le produit

66831-1-PBS cible ASGR2 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène ASGR2 Protéine recombinante Ag2037
Nom complet asialoglycoprotein receptor 2
Masse moléculaire calculée 39 kDa
Poids moléculaire observé 36 kDa
Numéro d’acquisition GenBankBC017251
Symbole du gène ASGR2
Identification du gène (NCBI) 433
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Asialoglycoprotein receptor (ASGPR), also known as the hepatic galactose/N-acetylglucosamine (GlcNAc) receptor or Ashwell receptor, is a C-type lectin expressed exclusively in hepatic parenchymal cells. ASGPR consists of two subunits, a major subunit (ASGR1, HL-1) and a minor subunit (ASGR2, HL-2), and specifically recognizes terminal β-linked galactose or GlcNAc on circulating glycoproteins or cells. This receptor plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins that contain terminal galactose or GlcNAc residues. ASGPR may facilitate hepatic infection by multiple viruses including hepatitis B, and is also a target for liver-specific drug delivery.

{{ptg:RelatedPrimaryAntibodies}}